ARCHIVES

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

This article is from The Cancer Letter archive.

Vol. 19 No. 38 | October 1, 1993

Download PDF Visit The Full Archive

Related Articles

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Hawking Hearings Turn Up Difference Between Management, Staff At FDA

November 20, 1981

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

November 12, 2004

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

October 27, 1978